We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Nicardipine on Kidney Function During Orthognathic Surgery Under Hypotensive Anesthesia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01175746
First Posted: August 5, 2010
Last Update Posted: June 13, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Yonsei University
  Purpose
Since nicardipine is known to protect kidney function, nicardipine infusion will result in better renal parameters measured in this study.

Condition Intervention
Healthy Subjects Drug: Nicardipine Drug: remifentanil

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by Yonsei University:

Primary Outcome Measures:
  • Creatinine Clearance [ Time Frame: 2hr after the start of hypotensive anesthesia ]

    Hypotensive anesthesia means that we maintain the mean blood pressure between 55 & 65 mmHg during surgery to decrease the blood loss.

    The specific time point is exactly 2hr after we star to lower the blood pressure.



Enrollment: 46
Study Start Date: August 2010
Study Completion Date: December 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: nicardipine Drug: Nicardipine
Active Comparator: remifentanil Drug: remifentanil
0.1-0.5 ugkg/min during hypotensive anesthesia
Other Name: ultiva®

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy adult patients undergoing hypotensive anesthesia

Exclusion Criteria:

  • patients with any co-morbidity
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01175746


Sponsors and Collaborators
Yonsei University
Investigators
Principal Investigator: Ji Young Kim Severance hospital, YUHS
  More Information

Responsible Party: Yonsei University
ClinicalTrials.gov Identifier: NCT01175746     History of Changes
Other Study ID Numbers: 3-2009-0196
First Submitted: August 2, 2010
First Posted: August 5, 2010
Last Update Posted: June 13, 2013
Last Verified: June 2013

Keywords provided by Yonsei University:
healthy adult patients
ASA class I
hypotensive anesthesia

Additional relevant MeSH terms:
Anesthetics
Remifentanil
Antihypertensive Agents
Nicardipine
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics, Opioid
Narcotics
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Hypnotics and Sedatives
Anesthetics, Intravenous
Anesthetics, General
Calcium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Vasodilator Agents